These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 18093171)
1. Oxidative stress on EAAC1 is involved in MPTP-induced glutathione depletion and motor dysfunction. Aoyama K; Matsumura N; Watabe M; Nakaki T Eur J Neurosci; 2008 Jan; 27(1):20-30. PubMed ID: 18093171 [TBL] [Abstract][Full Text] [Related]
2. Melatonin protects against oxidative stress caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the mouse nigrostriatum. Thomas B; Mohanakumar KP J Pineal Res; 2004 Jan; 36(1):25-32. PubMed ID: 14675127 [TBL] [Abstract][Full Text] [Related]
3. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum. Kawasaki T; Ishihara K; Ago Y; Baba A; Matsuda T J Pharmacol Exp Ther; 2007 Jul; 322(1):274-81. PubMed ID: 17429058 [TBL] [Abstract][Full Text] [Related]
4. Protective effects of neuronal nitric oxide synthase inhibitor in mouse brain against MPTP neurotoxicity: an immunohistological study. Watanabe H; Muramatsu Y; Kurosaki R; Michimata M; Matsubara M; Imai Y; Araki T Eur Neuropsychopharmacol; 2004 Mar; 14(2):93-104. PubMed ID: 15013024 [TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effect of metformin in MPTP-induced Parkinson's disease in mice. Patil SP; Jain PD; Ghumatkar PJ; Tambe R; Sathaye S Neuroscience; 2014 Sep; 277():747-54. PubMed ID: 25108167 [TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo evidences that antioxidant action contributes to the neuroprotective effects of the neuronal nitric oxide synthase and monoamine oxidase-B inhibitor, 7-nitroindazole. Thomas B; Saravanan KS; Mohanakumar KP Neurochem Int; 2008 May; 52(6):990-1001. PubMed ID: 18164516 [TBL] [Abstract][Full Text] [Related]
7. N-acetylcysteine prevents loss of dopaminergic neurons in the EAAC1-/- mouse. Berman AE; Chan WY; Brennan AM; Reyes RC; Adler BL; Suh SW; Kauppinen TM; Edling Y; Swanson RA Ann Neurol; 2011 Mar; 69(3):509-20. PubMed ID: 21446024 [TBL] [Abstract][Full Text] [Related]
8. Inhibitors of mitochondrial respiration, iron (II), and hydroxyl radical evoke release and extracellular hydrolysis of glutathione in rat striatum and substantia nigra: potential implications to Parkinson's disease. Han J; Cheng FC; Yang Z; Dryhurst G J Neurochem; 1999 Oct; 73(4):1683-95. PubMed ID: 10501216 [TBL] [Abstract][Full Text] [Related]
9. SEA0400, a specific Na+/Ca2+ exchange inhibitor, prevents dopaminergic neurotoxicity in an MPTP mouse model of Parkinson's disease. Ago Y; Kawasaki T; Nashida T; Ota Y; Cong Y; Kitamoto M; Takahashi T; Takuma K; Matsuda T Neuropharmacology; 2011 Dec; 61(8):1441-51. PubMed ID: 21903118 [TBL] [Abstract][Full Text] [Related]
10. Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse. Aoyama K; Suh SW; Hamby AM; Liu J; Chan WY; Chen Y; Swanson RA Nat Neurosci; 2006 Jan; 9(1):119-26. PubMed ID: 16311588 [TBL] [Abstract][Full Text] [Related]
11. Lutein protects dopaminergic neurons against MPTP-induced apoptotic death and motor dysfunction by ameliorating mitochondrial disruption and oxidative stress. Nataraj J; Manivasagam T; Thenmozhi AJ; Essa MM Nutr Neurosci; 2016 Jul; 19(6):237-46. PubMed ID: 25730317 [TBL] [Abstract][Full Text] [Related]
15. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease. Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060 [TBL] [Abstract][Full Text] [Related]
16. Role of nitric oxide synthase against MPTP neurotoxicity in mice. Kurosaki R; Muramatsu Y; Michimata M; Matsubara M; Kato H; Imai Y; Itoyama Y; Araki T Neurol Res; 2002 Oct; 24(7):655-62. PubMed ID: 12392201 [TBL] [Abstract][Full Text] [Related]
17. Apelin-36 mediates neuroprotective effects by regulating oxidative stress, autophagy and apoptosis in MPTP-induced Parkinson's disease model mice. Zhu J; Gao W; Shan X; Wang C; Wang H; Shao Z; Dou S; Jiang Y; Wang C; Cheng B Brain Res; 2020 Jan; 1726():146493. PubMed ID: 31586624 [TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effects of madecassoside in early stage of Parkinson's disease induced by MPTP in rats. Xu CL; Qu R; Zhang J; Li LF; Ma SP Fitoterapia; 2013 Oct; 90():112-8. PubMed ID: 23876367 [TBL] [Abstract][Full Text] [Related]
19. A neuroprotective agent, T-817MA (1-{3-[2-(1-benzothiophen-5-yl)ethoxy]propyl} azetidin-3-ol maleate), prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice. Kawasaki T; Ago Y; Kitao T; Nashida T; Takagi A; Takuma K; Matsuda T Neuropharmacology; 2008 Oct; 55(5):654-60. PubMed ID: 18573265 [TBL] [Abstract][Full Text] [Related]
20. Activation of apoptosis signal regulating kinase 1 (ASK1) and translocation of death-associated protein, Daxx, in substantia nigra pars compacta in a mouse model of Parkinson's disease: protection by alpha-lipoic acid. Karunakaran S; Diwakar L; Saeed U; Agarwal V; Ramakrishnan S; Iyengar S; Ravindranath V FASEB J; 2007 Jul; 21(9):2226-36. PubMed ID: 17369508 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]